LakePharma Announces Dedicated Vector Center to Support Gene and Cell TherapyAdded On: 2019-02-26
LakePharma Announces its GMP Biorepository Facility near Boston is Now Operational, Plans Additional HiringAdded On: 2019-01-15
LakePharma announces its cGMP microBiomanufacturing Center is now operationalAdded On: 2018-12-18
Added On: 2017-02-06
Monday February 6, 2017
LakePharma, the leading US-based biologics CRO, announced today the appointment of Aaron Sato, Ph.D. to the newly created Chief Scientific Officer (CSO) position.
“Since starting in 2009, LakePharma has experienced significant growth and success in becoming the largest US-based biologics CRO," said Hua Tu, Ph.D., Founder and CEO. "In response to our broad customer base, which has been greatly expanded with the acquisition of Blue Sky Bioservices, we are formalizing our top antibody specialists into one site. We are thrilled to have Dr. Sato lead the new LakePharma Antibody Center."
“Therapeutic antibody discovery and engineering represent a significant market opportunity. It is remarkable that our vision and track record was able to attract top antibody engineers such as Aaron to the team," commented John "Lippy" Lippincott, Ph.D., VP of Antibody Discovery.
"I have been a long-standing client of LakePharma and have always been impressed by their quality and productivity. During my career, I have always loved building and leading teams focused on discovering novel biologics, which aligns well with LakePharma's commitment to build a state-of-the-art antibody center. I look forward to leading LakePharma's expansion into the antibody discovery and engineering space and helping others discover drugs that can help patients," said Aaron Sato, Ph.D., CSO.
Aaron Sato received his doctorate in Biological Chemistry from MIT with 18 years of industry experience. Prior to LakePharma, he held management positions at Dyax, Oncomed and Sutro. He is an author of over 30 peer reviewed papers, 40 issued patents in the antibody space, and is a well-known speaker and organizer in the top scientific conferences.
LakePharma is the leading contract research organization (CRO) specializing in antibody engineering, antibody discovery, molecular engineering, protein chemistry, bioexpression, biofunction, bioprocessing, and bioanalytics. LakePharma focuses on integrated platforms to support projects throughout the drug discovery process. LakePharma offers dedicated client services and sophisticated software to provide real-time access to project data via a secure cloud-based portal. For more information, please visit lakepharma.com
VP Commercial Operations